Furthermore, to assess potential interactions between gut microbiome metabolites and amyloidogenic human proteins, we modeled interactions of bacterial functional amyloid CsgA with human alpha-synuclein, whose aggregation is a hallmark of Parkinson’s disease, and with hIAPP, which is involved in type 2 diabetes. Here, SNCA is linked to Parkinson disease.